Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
recombinant hepatitis E and hepatitis B vaccine
- Development stage
- Unknown
- Lead developer
- Xiamen Innovax Biotech
- Modality
- Recombinant Proteins and Enzymes, Vaccines & Immunotherapeutics
- Administration
- Intramuscular
01
Overview
The recombinant hepatitis E and hepatitis B vaccine is a combination vaccine candidate developed by Xiamen Innovax Biotech to provide simultaneous protection against Hepatitis E Virus (HEV) and Hepatitis B Virus (HBV). The vaccine formulation typically incorporates the recombinant HEV capsid protein (specifically the HEV 239 antigen used in the approved Hecolin vaccine) and the Hepatitis B surface antigen (HBsAg). By combining these two antigens, the product aims to simplify immunization schedules and improve coverage in regions where both viruses are endemic. Clinical development has focused on evaluating the safety, immunogenicity, and potential interference between the two components when administered as a single injection.
- Other names
- HEV-HBV combination vaccineCombined recombinant hepatitis E and hepatitis B vaccinehepatitis E vaccine + hepatitis B vaccine
02
Targets
HBsAg (Hepatitis B surface antigen)HEV ORF2 (Hepatitis E virus capsid protein)
Beyond the preview
Go deeper on recombinant hepatitis E and hepatitis B vaccine.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on recombinant hepatitis E and hepatitis B vaccine.